Covid immunization: Bharat Biotech to utilize ViroVax’s adjuvant for Covaxin Kumar Jeetendra | October 5, 2020 Trials, will use adjuvant Alhydroxiquim-II to boost immune response and longer lasting immunity. The technology has been used under this licensing arrangement with US-based ViroVax. Adjuvant is used to boost the vaccine efficacy. Covaxin is an inactivated vaccine derived from a strain of SARS-CoV-2 virus, isolated in the National Institute of Virology (NIV), Pune under …
Multisensor Plant Phenotyping System Delivers Standardised Data Kumar Jeetendra | October 5, 2020 Configurable with a wide range of sensors, the new HyperAixpert multisensor plant phenotyping system from Analytik draws upon advanced machine-learning based analytical software with an intuitive experiment driven design to ensure that your data acquisition is both standardised and repeatable. Suitable for a range of sample types, the high-resolution sensors on the HyperAixpert enable rapid …
Moderna antibody preliminary temporary workers neglect to select enough minorities, inciting lull Kumar Jeetendra | October 6, 2020 Private contractors hired by Moderna Inc to recruit volunteers for its coronavirus vaccine trial failed to enrol enough Black, Latino and Native American participants to ascertain how well the vaccine works in such populations, company executives and vaccine researchers told Reuters. To compensate for the shortfall, Moderna slowed registration of its late-stage trial and educated …
Seeing how the malaria can withstand fever’s warmth Kumar Jeetendra | October 6, 2020 Even when a man suffering from malaria is burning up with fever and too ill to operate, the little blood-eating parasites lurking inside them continue to flourish, relentlessly growing and multiplying as they gobble up the host’s red blood cells. The single-celled Plasmodium parasites that cause 200 million cases of malaria annually can withstand feverish …
Study shows tofacitinib medication can fix porousness absconds in the digestive tract Kumar Jeetendra | October 6, 2020 A team of researchers led by biomedical scientist Declan F. McCole in the University of California, Riverside, has found that the medication tofacitinib, also called Xeljanz and approved by the FDA to treat rheumatoid arthritis and ulcerative colitis, can fix permeability defects in the intestine. Study results appear in the Journal of Crohn’s and Colitis. …
Lupin gets USFDA gesture to showcase drug for treating backsliding various sclerosis Kumar Jeetendra | October 6, 2020 The company has received approval from the United States Food and Drug Administration (USFDA) to advertise its own Dimethyl Fumarate delayed-release capsules in the strengths of 120 mg and 240 mg, Lupin said in a statement. The item is a generic version of Biogen Inc”s Tecfidera delayed-release capsules at the same strengths, it added. The …
Glenmark Pharma gets USFDA gesture to showcase drug for backsliding numerous sclerosis Kumar Jeetendra | October 7, 2020 Drug major Glenmark Pharma on Wednesday said it has received final approval from the US health regulator for Dimethyl Fumarate delayed-release capsules, used for treatment of relapsing forms of multiple sclerosis in adults. Quoting IQVIA sales data for the 12 month period ending August 2020, Glenmark said Tecfidera delayed-release capsules, 120 mg and 240 mg, …
Amniotic liquid undifferentiated cells may prompt better treatment for ischemic stroke Kumar Jeetendra | October 7, 2020 A study published today in STEM CELLS Translational Medicine points the way to a potential new avenue of treatment for ischemic stroke. The study, led by Annamaria Cimini, Ph.D., of the University of L’Aquila, and Liborio Stuppia, M.D., of D’Annunzio University, Italy, shows how the secretome of amniotic fluid stem cells can restore neuronal plasticity …
Designers develop plant-based splash that could be utilized in N95 mask filters Kumar Jeetendra | October 7, 2020 Engineers have invented a way to spray extremely thin wires made of a plant-based material that might be used in N95 mask filters, devices that harvest energy for electricity, and potentially the production of human organs. The procedure involves spraying methylcellulose, a renewable plastic material derived from plant cellulose, on 3D-printed and other objects ranging …
Biocartis Announces Market Release of SeptiCyte® RAPID test on Idylla™ Kumar Jeetendra | October 7, 2020 Mechelen, Belgium, 6 October 2020 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces the market release of SeptiCyte® RAPID on Idylla™ as a CE-marked IVD test. SeptiCyte® RAPID is a host-response test1 that distinguishes sepsis from non-infectious systemic inflammation in patients suspected of sepsis and …
Hamdard Laboratories Launches ‘Immunity Booster’ and ‘Respiratory Health’ Kits Kumar Jeetendra | October 8, 2020 New Delhi, October 8, 2020: To offer complete wellness and health solutions, Hamdard Laboratories (Medicine Division), India’s most trusted Unani brand, today introduced ‘Immunity Booster’ and ‘Respiratory Health’ Kits to build a strong immunity and upkeep respiratory health system. The Unani medicine Kits have some amazing health and wellness products which are known for their …
CellGenix Completes Facility Expansion to Stay Ahead of the Increasing Demand for GMP Raw Materials Kumar Jeetendra | October 8, 2020 FREIBURG, Germany, October 08, 2020 / B3C newswire / — CellGenix GmbH, a pioneer for GMP grade reagents and a leading global supplier of high quality raw and ancillary materials for cell and gene therapies, announces the completion of the second phase of their facility expansion. CellGenix has reconstructed and expanded their production facility for …
